Join the 155,000+ IMP followers

www.medical-devices.tech

Table-Integrated Surgical Robot Enters Commercial Hospital Use

Johnson & Johnson installs the OTTAVA Robotic Surgical System at Memorial Hermann-Texas Medical Center, its first commercial site for soft-tissue robotic surgery.

  www.jnjmedtech.com
Table-Integrated Surgical Robot Enters Commercial Hospital Use

Hospital operating rooms, general surgery and robotic-assisted minimally invasive surgery are the application areas of the first commercial installation of the OTTAVA Robotic Surgical System from Johnson & Johnson. Memorial Hermann-Texas Medical Center in Houston, Texas, will be the first hospital in the United States to use the system, as part of Johnson & Johnson's early access commercial program for its soft-tissue surgical robotics platform.

Operating Room Constraints in Robotic Surgery
Hospitals introducing or expanding robotic-assisted surgery face recurring constraints: limited operating room floor space, complex setup and turnover workflows, growing procedure demand and pressure on staff and budgets. Conventional surgical robots typically use separate patient-side carts that occupy space around the table and must be positioned for each case. These factors limit how many robotic procedures a single operating room can support.

Table-Integrated System Architecture
OTTAVA integrates four robotic arms into a standard-sized surgical table. Because the arms are part of the table rather than mounted on separate carts, the system is designed to keep the floor area around the patient free and to reduce positioning steps before and during procedures. The architecture includes software-controlled automation capabilities, next-generation robotic instrumentation and compatibility with the Polyphonic Digital Ecosystem, Johnson & Johnson's platform for connecting surgical data and devices. According to the company, the design aims to expand operating room capacity, streamline clinical workflows and maintain procedural momentum.

Regulatory Authorization and Indications
The U.S. Food and Drug Administration granted De Novo authorization for OTTAVA in July 2026, making it the first FDA-authorized table-integrated soft-tissue robotic surgical system. It is authorized for ten general surgery procedures in the upper abdomen: Roux-en-Y gastric bypass, gastrectomy, cholecystectomy, splenectomy, gastric sleeve, small bowel resection, appendectomy, lysis of adhesions, fundoplication and hiatal hernia repair.

Why Memorial Hermann Was Selected
The installation builds on years of clinical collaboration. Memorial Hermann-Texas Medical Center served as a clinical trial site in the Investigational Device Exemption (IDE) program that supported regulatory authorization, including clinical evaluation of OTTAVA in Roux-en-Y gastric bypass. Surgical teams at the site are therefore already familiar with the system's workflow, which reduces the learning phase associated with introducing a new robotic platform into routine practice.

Deployment and Evidence Generation
Johnson & Johnson will support the hospital's use of the system and the generation of clinical data and real-world evidence. The commercial launch will continue with select customers in the United States, focusing on early customer success, while the platform is evaluated for additional indications.

"As we bring OTTAVA to market, our focus goes beyond introducing a new technology. We will work alongside health systems and surgical teams, bringing the breadth of Johnson & Johnson to support expanding access to robotic surgery, improve workflow and procedural efficiencies, and address the evolving needs of care teams," said Tim Schmid, Executive Vice President, Worldwide Chairman, MedTech, Johnson & Johnson.

"We designed OTTAVA around the real-world challenges facing hospitals, surgeons and care teams, and collaboration has been fundamental to that process," said Hani Abouhalka, Company Group Chair, Surgery, MedTech, Johnson & Johnson.

Edited by Evgeny Churilov, Induportals Media - Adapted by AI.

www.jnjmedtech.com

  Ask For More Information…

LinkedIn
Pinterest

Join the 155,000+ IMP followers

International